| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025418972 |
| P356 | DOI | 10.1186/1465-9921-14-24 |
| P932 | PMC publication ID | 3620569 |
| P698 | PubMed publication ID | 23425215 |
| P5875 | ResearchGate publication ID | 235680894 |
| P50 | author | Laura M O Caram | Q82860854 |
| Suzana Erico Tanni | Q56945593 | ||
| Irma Godoy | Q60663101 | ||
| P2093 | author name string | Renata Ferrari | |
| Camila R Corrêa | |||
| Corina Corrêa | |||
| P2860 | cites work | Inflammatory response and body composition in chronic obstructive pulmonary disease | Q77158102 |
| Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease | Q79786400 | ||
| Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease | Q83266327 | ||
| Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study | Q83313267 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score | Q33683010 | ||
| Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. | Q33939434 | ||
| ATS Statement | Q34136219 | ||
| Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype | Q34280020 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| Interleukin-6: from basic science to medicine--40 years in immunology | Q36072403 | ||
| Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects | Q36148605 | ||
| Raised CRP levels mark metabolic and functional impairment in advanced COPD. | Q36148662 | ||
| C-reactive protein in patients with COPD, control smokers and non-smokers | Q36148673 | ||
| C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease | Q36184252 | ||
| Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars | Q36215688 | ||
| Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. | Q36383938 | ||
| Chronic inflammation is associated with low physical function in older adults across multiple comorbidities | Q37132103 | ||
| The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year | Q37168309 | ||
| Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease | Q37828179 | ||
| Interleukin-6: from an inflammatory marker to a target for inflammatory diseases | Q38033779 | ||
| Validation of a combined comorbidity index | Q39605818 | ||
| Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein | Q39800710 | ||
| C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease | Q40277494 | ||
| C-reactive protein levels and survival in patients with moderate to very severe COPD. | Q44580491 | ||
| Interleukin-6: a red herring or a real catch in COPD? | Q50663065 | ||
| The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). | Q53182496 | ||
| Systemic Inflammation and COPD | Q57072926 | ||
| Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease | Q57955696 | ||
| Three-year follow-up study of respiratory and systemic manifestations of chronic obstructive pulmonary disease. | Q64986779 | ||
| The biology of interleukin-6 | Q69086773 | ||
| Standardization of spirometry--1987 update. Statement of the American Thoracic Society | Q69438135 | ||
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 24 | |
| P577 | publication date | 2013-02-20 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease | |
| P478 | volume | 14 |
| Q36754116 | A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese Population |
| Q58700499 | A model of cigarette smoke induced COPD identifies Nrf2 signaling as an expedient target for intervention |
| Q23914900 | Age impacts pulmonary inflammation and systemic bone response to inhaled orgnic dust exposure |
| Q36206448 | Anti-inflammatory effects of potato extract on a rat model of cigarette smoke-induced chronic obstructive pulmonary disease |
| Q64062832 | Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD |
| Q90708070 | Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway |
| Q39448575 | Beyond BMI: Obesity and Lung Disease. |
| Q64235328 | Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis |
| Q47112547 | Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study |
| Q92168193 | C-Reactive Protein and All-Cause Mortality in Patients with Stable Coronary Artery Disease: A Secondary Analysis Based on a Retrospective Cohort Study |
| Q35312449 | Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers |
| Q35892456 | Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD |
| Q33568552 | Cytokine inhibition in the treatment of COPD. |
| Q96306099 | Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients |
| Q58770879 | Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation |
| Q36000101 | Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease |
| Q38843459 | Ghrelin Inhibits Interleukin-6 Production Induced by Cigarette Smoke Extract in the Bronchial Epithelial Cell Via NF-κB Pathway |
| Q38768300 | HIV infection model of chronic obstructive pulmonary disease in mice |
| Q38710985 | Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease. |
| Q88758561 | Indoor black carbon and biomarkers of systemic inflammation and endothelial activation in COPD patients |
| Q34005625 | Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD. |
| Q43081658 | Interleukin-6 and statin therapy: potential role in the management of COPD. |
| Q38468602 | Microarray analysis of long non-coding RNAs in COPD lung tissue. |
| Q34539050 | Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot study |
| Q33569149 | Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma |
| Q35077055 | Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. |
| Q37501498 | Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD |
| Q42146567 | Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients |
| Q50602624 | Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. |
| Q29048648 | Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust |
| Q37734257 | Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease |
| Q33755148 | The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations. |
| Q52690066 | The Effect of Inhalant Organic Dust on Bone Health. |
| Q38608866 | The Gut-Liver-Lung Axis. Modulation of the Innate Immune Response and Its Possible Role in Chronic Obstructive Pulmonary Disease |
| Q90150606 | The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: Il6 Responses to Exercise |
| Q36105708 | Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema |
| Q34656726 | Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities. |
| Q54285962 | [Clinical significance of hypersensitive C-reactive protein, fribrinogen and D-dimmer in connective tissue disease-related interstitial lung disease]. |
Search more.